MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
MariMed's gross profit for the twelve months ending Sep 30, 2026 was $59.16M, down 1.5% year over year. For fiscal 2025 it was $57.88M, down 7.6% from the year before. The highest annual figure on record is $66.26M in fiscal 2021.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.88M | -7.6% |
| FY2024 | Dec 31, 2024 | $62.61M | -5.0% |
| FY2023 | Dec 31, 2023 | $65.92M | +3.1% |
| FY2022 | Dec 31, 2022 | $63.96M | -3.5% |
| FY2021 | Dec 31, 2021 | $66.26M | +111.5% |
| FY2020 | Dec 31, 2020 | $31.32M | +67.5% |
| FY2019 | Dec 31, 2019 | $18.70M | +139.4% |
| FY2018 | Dec 31, 2018 | $7.81M | +101.6% |
| FY2017 | Dec 31, 2017 | $3.88M | +99.1% |
| FY2016 | Dec 31, 2016 | $1.95M | – |
| FY2015 | Dec 31, 2015 | -$296.65K | – |
| FY2014 | Dec 31, 2014 | -$101.78K | – |
| FY2013 | Dec 31, 2013 | -$25.38K | – |
| FY2012 | Dec 31, 2012 | -$19.16K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $17.16M | +4.9% |
| Q2 FY2026 | Jun 30, 2026 | $16.23M | +1.9% |
| Q1 FY2026 | Mar 31, 2026 | $15.28M | +1.2% |
| Q4 FY2025 | Dec 31, 2025 | $10.50M | -17.0% |
| Q3 FY2025 | Sep 30, 2025 | $16.36M | -2.5% |
| Q2 FY2025 | Jun 30, 2025 | $15.93M | -5.8% |
| Q1 FY2025 | Mar 31, 2025 | $15.09M | -8.4% |
| Q4 FY2024 | Dec 31, 2024 | $12.66M | -26.9% |
| Q3 FY2024 | Sep 30, 2024 | $16.78M | -0.3% |
| Q2 FY2024 | Jun 30, 2024 | $16.91M | +3.3% |
| Q1 FY2024 | Mar 31, 2024 | $16.47M | +7.0% |
| Q4 FY2023 | Dec 31, 2023 | $17.32M | +9.5% |
| Q3 FY2023 | Sep 30, 2023 | $16.84M | +4.2% |
| Q2 FY2023 | Jun 30, 2023 | $16.38M | +9.1% |
| Q1 FY2023 | Mar 31, 2023 | $15.39M | -9.4% |
| Q4 FY2022 | Dec 31, 2022 | $15.81M | +2.1% |
| Q3 FY2022 | Sep 30, 2022 | $16.16M | +22.6% |
| Q2 FY2022 | Jun 30, 2022 | $15.01M | +29.1% |
| Q1 FY2022 | Mar 31, 2022 | $16.98M | +95.6% |
| Q4 FY2021 | Dec 31, 2021 | $15.49M | +151.5% |
| Q1 FY2021 | Mar 31, 2021 | $13.19M | +170.9% |
| Q4 FY2020 | Dec 31, 2020 | $11.62M | +313.0% |
| Q3 FY2020 | Sep 30, 2020 | $8.68M | +84.7% |
| Q2 FY2020 | Jun 30, 2020 | $6.16M | -31.0% |
| Q1 FY2020 | Mar 31, 2020 | $4.87M | +115.3% |
| Q4 FY2019 | Dec 31, 2019 | $2.81M | +3.3% |
| Q3 FY2019 | Sep 30, 2019 | $4.70M | +151.4% |
| Q2 FY2019 | Jun 30, 2019 | $8.93M | +341.1% |
| Q1 FY2019 | Mar 31, 2019 | $2.26M | +89.4% |
| Q4 FY2018 | Dec 31, 2018 | $2.72M | +210.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.87M | +60.2% |
| Q2 FY2018 | Jun 30, 2018 | $2.02M | +75.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.19M | +75.7% |
| Q4 FY2017 | Dec 31, 2017 | $876.11K | +14.6% |
| Q3 FY2017 | Sep 30, 2017 | $1.17M | +159.0% |
| Q2 FY2017 | Jun 30, 2017 | $1.15M | – |
| Q1 FY2017 | Mar 31, 2017 | $679.65K | – |
| Q4 FY2016 | Dec 31, 2016 | $764.75K | – |
| Q3 FY2016 | Sep 30, 2016 | $450.83K | – |
See a number that looks wrong?